ClassID:

112582

C12Q1/62 - CPC Classification

Classification description:

Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving uric acid

Recent Application in this class:
#1
20230192555
2023-06-22

NITROGEN-SULFUR CO-DOPED TI3C2-MXENE NANOSHEET AND PREPARATION METHOD AND APPLICATION THEREOF

#2
20210009578
2021-01-14

Disposable sensor chip with reagent including 2-substituted benzothiazolyl-3-substituted phenyl-5-substituted sulfonated phenyl-2H-tetrazolium salt

#3
20200190539
2020-06-18

In vitro recombination method

#4
20190185465
2019-06-20

2-substituted benzothiazolyl-3-substituted phenyl-5-substituted sulfonated phenyl-2H-tetrazolium salt, reagent for biological component concentration measurement containing said salt, and biological component concentration measurement method using said salt

#5
20180282707
2018-10-04

Mutant-type uricase, PEG modified mutant-type uricase, and application thereof

#6
20180208965
2018-07-26

Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method

#7
20170233764
2017-08-17

In vitro recombination method

#8
20170211125
2017-07-27

Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method

#9
20170007172
2017-01-12

CORRELATION OF SALIVA FLOW-RATE AND ORAL DRYNESS IN HYPERURICEMIA

#10
20140323322
2014-10-30

METHOD AND APPARATUS FOR CHEMICAL SENSING USING 2D PHOTONIC CRYSTAL ARRAYS

#11
20130023000
2013-01-24

Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method

#12
20120100563
2012-04-26

Devices and formulations for detecting, screening and monitoring levels of certain constituents in bodily fluids and method

#13
20110281287
2011-11-17

Size self-limiting compositions and test devices for measuring analytes in biological fluids

#14
20110243911
2011-10-06

Method for the preventing and/or treating IL-1 beta lung pathology in mammals by administering a uric acid reducing compound

#15
20100184187
2010-07-22

In vitro recombination method

#16
20090123955
2009-05-14

Size self-limiting compositions and test devices for measuring analytes in biological fluids

#17
20070037197
2007-02-15

In vitro recombination method